VEEA.NASDAQVeea INC

DEF: VEEA Seeks Reverse Stock Split, Boosts Equity Plan

Sentiment:

Proxy Statement for Annual Meeting


Veea Inc. calls for its 2025 Annual Meeting to vote on a reverse stock split to address Nasdaq non-compliance and an increase in its equity incentive plan shares.

Capital raiseOn August 12, 2025, the company entered into a Placement Agency Agreement for a registered public offering of up to 9,239,096 shares of common stock with accompanying common warrants.The offering closed on August 14, 2025, at a public offering price of $1.00 per common share with one accompanying Investor Warrant.Gross proceeds from the offering were approximately $6.0 million, with net proceeds of approximately $5.3 million after deducting fees and expenses.Included in the purchased securities were 3,239,096 shares of common stock and warrants issued to NLabs Inc., an affiliate of the CEO, in exchange for the extinguishment of $3,239,096 of outstanding promissory notes and accrued interest.
Worse than expectedThe company received a Nasdaq Stock Price Noncompliance Notice on September 29, 2025, as its common stock traded below $1.00 for 30 consecutive business days.The closing bid price on December 1, 2025, was $0.46, significantly below the Nasdaq minimum bid price requirement.The proposed reverse stock split is a reactive measure to avoid delisting, indicating underlying challenges with stock performance.

Summary

  • Veea Inc. will hold its 2025 Annual Meeting virtually on December 30, 2025, at 10:00 AM Eastern Time.
  • Stockholders will vote on the election of two Class I directors, Michael Salmasi and Gary Cohen, for three-year terms expiring at the 2028 Annual Meeting.
  • A key proposal is to approve an amendment to the Certificate of Incorporation to effect a reverse stock split of common stock, with a ratio between 1:2 and 1:20, to be determined by the Board. This is primarily to regain compliance with Nasdaq's $1.00 minimum bid price requirement by March 30, 2026, following a non-compliance notice received on September 29, 2025, when the stock price was $0.46 on December 1, 2025.
  • Another significant proposal is to amend the 2024 Equity Incentive Plan to increase the maximum aggregate number of shares available for issuance to 9,546,421, plus an annual increase of up to 3% of outstanding shares from January 1, 2026, through January 1, 2034. This aims to attract and retain talent.
  • Stockholders will also vote on ratifying PKF OConnor Davies, LLP as the independent auditor for 2025, an advisory vote on executive compensation, and an advisory vote on the frequency of future executive compensation votes (Board recommends every three years).
  • The company had approximately 50,100,819 shares of common stock issued and outstanding as of the November 3, 2025, Record Date.

Sentiment

Score: 4

Explanation: The filing addresses critical governance and listing issues, demonstrating proactive management. However, the underlying need for a reverse stock split due to low stock price and the potential for dilution from increased equity awards and unreduced authorized shares present significant negative aspects. The related party transactions also warrant scrutiny.

Positives

  • The Board is actively addressing Nasdaq listing compliance issues by proposing a reverse stock split.
  • The proposed increase in the 2024 Equity Incentive Plan shares aims to enhance the company's ability to attract, retain, and motivate key employees, directors, and consultants.
  • The company maintains robust corporate governance practices, including a classified board, independent directors, and established audit, compensation, and nominating/corporate governance committees.
  • An Executive Compensation Clawback Policy is in place, allowing for mandatory recovery of erroneously awarded incentive-based compensation in the event of financial restatements due to fraud or intentional illegal conduct.
  • The company has adopted Corporate Governance Guidelines and a Code of Business Conduct and Ethics applicable to all employees, officers, and directors.

Negatives

  • The necessity of a reverse stock split indicates the company's common stock has fallen below Nasdaq's minimum bid price requirement ($1.00 per share for 30 consecutive business days, with a closing price of $0.46 on December 1, 2025), signaling poor stock performance.
  • The reverse stock split, without a proportional reduction in authorized shares, could increase the Board's ability to issue more shares without further stockholder approval, potentially leading to future dilution for existing stockholders.
  • The increase in shares reserved under the 2024 Equity Incentive Plan, while intended for talent retention, represents potential future dilution for current stockholders (9,546,521 shares represent approximately 19% of outstanding shares as of November 3, 2025).
  • The Annual Meeting will be held virtually, and stockholders of record will not be able to ask questions prior to or during the meeting, limiting direct engagement.
  • The company has significant related party transactions, including lease agreements and promissory notes with NLabs Inc. and Salmasi 2004 Trust, both affiliates of CEO Allen Salmasi, with accrued and unpaid rent totaling $1,836,000 (NLabs) and $2,088,000 (83rd Street LLC) as of June 30, 2025.

Risks

  • Delisting Risk: There is no assurance that the reverse stock split will sufficiently increase the stock price or maintain it above the $1.00 minimum bid price, potentially leading to delisting from Nasdaq.
  • Market Price Volatility: The market price of common stock may not increase proportionately to the reverse stock split ratio, or it may decrease to its pre-split level, reducing the company's market capitalization.
  • Dilution Risk: The unreduced number of authorized shares post-reverse split, combined with the increased equity incentive plan, could facilitate future share issuances that dilute existing stockholders' ownership and voting power.
  • Increased Transaction Costs: The reverse stock split could increase the number of stockholders holding "odd lots" (less than 100 shares), which typically incur higher per-share transaction costs when sold.
  • Anti-Takeover Effect: The availability of authorized but unissued shares could be used by the Board to deter hostile takeover attempts or delay changes in control, potentially entrenching current management.
  • Cybersecurity Risks: The company faces cybersecurity risks, with oversight by the audit committee, but the filing does not detail specific mitigation strategies or the extent of these risks.
  • Legal Claims: Awareness of several non-material claims alleging unpaid fees under ordinary course vendor or contractor agreements.

Future Outlook

The Board aims to increase the per-share trading price of common stock through a reverse stock split to ensure continued compliance with Nasdaq listing requirements and enhance marketability to institutional investors. The company also seeks to strengthen its ability to attract and retain talent by significantly increasing the share reserve for its 2024 Equity Incentive Plan. However, there is no assurance that the reverse stock split will achieve the desired price increase or maintain Nasdaq listing, and potential dilution from increased share authorization is a consideration.

Management Comments

  • "On behalf of the Board of Directors and management, it is my pleasure to express our appreciation for your continued support." Allen Salmasi, Chairman and CEO.
  • "We believe strongly that the increase in shares of common stock reserved for issuance with respect to awards granted under the 2024 Plan and the increase in the maximum number of shares of common stock which may be issued pursuant to Incentive Awards under the 2024 Plan is essential to our continued success and therefore is in the best interests of the Company and our stockholders."
  • "Our employees are our most valuable assets. The Board believes that grants of stock options, restricted stock units, performance-based restricted stock units and other equity awards under the 2024 Plan help create long-term equity participation in the Company and thereby assist us in attracting, retaining, motivating and rewarding employees, directors, and consultants."
  • "The Board believes that current and prospective investors will view an investment in our common stock more favorably if our common stock remains listed on Nasdaq."
  • "The Board recommends that you vote for every three (3) years as the desired frequency for us to hold a non-binding, advisory vote of the stockholders on executive compensation."

Industry Context

The company's proposal for a reverse stock split is a common strategy employed by companies facing delisting from major exchanges like Nasdaq due to low share prices. Maintaining a listing is crucial for liquidity and attracting institutional investors, many of whom have policies against holding lower-priced stocks. The increase in the equity incentive plan is consistent with industry practices to use stock-based compensation as a key tool for talent acquisition and retention, aligning executive interests with long-term stockholder value.

Comparison to Industry Standards

  • The company's executive compensation program is designed to be competitive with "comparable companies" and aims to align executive pay with long-term stockholder value creation through equity incentives, which is a standard industry practice.
  • The Board's recommendation for a triennial "Say-on-Pay" vote frequency is a common approach, allowing sufficient time to evaluate the long-term impact of equity compensation programs, though some companies opt for annual or biennial votes.
  • The company's audit committee structure, with independent directors and an audit committee financial expert (Douglas Maine), aligns with Nasdaq listing standards and best practices for public companies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board StructureThe Board consists of seven directors, divided into three staggered classes (Class I, II, III) with three-year terms. Four directors (Douglas Maine, Kanishka Roy, Gary Cohen, Alan Black) are determined to be independent under Nasdaq listing rules.NAProvides continuity and stability to the board, but staggered terms can make changes in control more difficult.
Committee CompositionThe Board has an Audit Committee (Chair: Douglas Maine, members: Gary Cohen, Alan Black), a Compensation Committee (Chair: Gary Cohen, member: Douglas Maine), and a Nominating and Corporate Governance Committee (Chair: Kanishka Roy, member: Alan Black). Douglas Maine qualifies as an audit committee financial expert.NAEnsures specialized oversight in key areas like financial reporting, executive compensation, and director nominations, enhancing governance quality.
Risk OversightThe Board oversees risk management directly and through its committees, with the Audit Committee specifically overseeing financial reporting, operational, privacy, cybersecurity, competition, legal, regulatory, compliance, and reputational risks.NAEstablishes a structured approach to identifying and mitigating various corporate risks, crucial for long-term stability.
Policies and ProceduresCorporate Governance Guidelines and a Code of Business Conduct and Ethics are in place and publicly available. An Executive Compensation Clawback Policy has been adopted in accordance with Final Clawback Rules.NAPromotes ethical conduct, transparency, and accountability across the organization, and provides a mechanism to recover incentive compensation in cases of financial restatement.

Legal Proceedings

  • Awareness of several non-material claims alleging unpaid fees under ordinary course vendor or contractor agreements.

Related Party Transactions

  • 2025 Public Offering: NLabs Inc., an entity controlled by CEO Allen Salmasi and his immediate family, purchased 3,239,096 shares of common stock and accompanying warrants in the August 2025 public offering in exchange for extinguishing $3,239,096 of outstanding non-convertible promissory notes and accrued interest.
  • Lease Arrangements with NLabs Inc.: The company has a sublease agreement with NLabs Inc. (an affiliate of CEO Allen Salmasi) for office space, renewed until December 31, 2025. Rent expense was $61,200 for Q1 2025 and Q1 2024, with accrued unpaid rent of $1,836,000 as of June 30, 2025.
  • Lease Arrangements with 83rd Street LLC: The company has a lease agreement with 83rd Street LLC (sole member is Salmasi 2004 Trust, grantor is CEO Allen Salmasi) for office space, renewed until December 31, 2025. Rent expense was $72,000 for Q1 2025, with accrued unpaid rent of $2,088,000 as of June 30, 2025. Rent for both leases is accrued and not paid in cash.
  • Related Party Debt from NLabs Inc.: NLabs Inc. made loans totaling $1,030,000 through November 30, 2025, evidenced by promissory notes with 10% annual interest, payable by March 31, 2026, or on demand. NLabs Inc. also made $30,000 in advances through the Record Date.
  • Conversion of Previous Related Party Debt: Previous Bridge Notes ($9,500,000) and Promissory Notes ($3,098,000) from NLabs Inc. were converted into common stock at $5.00 per share concurrent with the Business Combination on September 13, 2024.
  • Private Veea Common Stock Warrants: Warrants issued to CEO Allen Salmasi (for loan guarantee) and NLabs Inc. (for Bridge Notes) were exercised on a net basis at the Business Combination closing, resulting in 3,880,000 shares of common stock.

Stakeholder Impact

  • Shareholders: Face potential dilution from the increased equity incentive plan and the reverse stock split if authorized shares are not proportionally reduced. The reverse stock split aims to maintain Nasdaq listing, which is beneficial for liquidity and marketability, but carries risks of disproportionate price increase and increased transaction costs for odd-lot holders. Limited ability to ask questions at the virtual annual meeting.
  • Employees: Benefit from the expanded 2024 Equity Incentive Plan, which is designed to attract, motivate, and retain talent through equity awards, aligning their interests with long-term company performance.
  • Management: The Board's discretion in setting the reverse stock split ratio and the increased authorized shares could provide flexibility for strategic actions, potentially including anti-takeover measures. Executive compensation is subject to advisory votes and a clawback policy.
  • Creditors: Related party debt from NLabs Inc. indicates ongoing financial support from affiliates, which could be a positive for short-term liquidity, but also highlights reliance on related parties.

Next Steps

  • Stockholders to vote on all seven proposals at the Annual Meeting on December 30, 2025.
  • If approved, the Board will determine the exact ratio and timing for the reverse stock split and file the Certificate of Amendment with the Delaware Secretary of State.
  • The company must regain compliance with Nasdaq's $1.00 minimum bid price requirement by March 30, 2026, or seek an additional grace period.
  • If approved, the 2024 Equity Incentive Plan will be amended to increase the share reserve, enabling future equity grants to employees, directors, and consultants.
  • The company will continue to operate under the guidance of its Board and committees, including oversight of cybersecurity risks and financial reporting.

Key Dates

DateDescription
March 1, 2014Initial sublease agreement with NLabs Inc. for office space.
April 2017Initial lease agreement with 83rd Street LLC for office space.
August 2023PKF OConnor Davies, LLP began serving as independent registered public accounting firm.
September 13, 2024Business Combination consummated; Related Party Notes converted into common stock.
November 11, 2024Compensation Committee approved a $40,000 discretionary special cash bonus to Ms. Smith.
December 30, 2024Board approved an equity award of 2,992,475 non-qualified stock options to Mr. Salmasi.
December 31, 2024Fiscal year end for the 2024 Annual Report.
May 2025Randal V. Stephenson joined Veea as Senior Vice President and Chief Financial Officer.
August 12, 2025S-1 registration statement declared effective; Placement Agency Agreement entered for public offering.
August 14, 2025Public Offering closed, raising approximately $6.0 million gross proceeds.
September 29, 2025Received Nasdaq Stock Price Noncompliance Notice for falling below $1.00 per share for 30 consecutive business days.
November 3, 2025Record Date for stockholders entitled to vote at the Annual Meeting.
November 12, 2025Board approved the amendment to the 2024 Equity Incentive Plan.
December 1, 2025Closing trading price of common stock was $0.46.
December 4, 2025Notice of Annual Meeting and Proxy Statement first distributed.
December 29, 2025Deadline for internet voting and proxy revocation (11:59 p.m. ET).
December 30, 2025Annual Meeting of Stockholders to be held virtually (10:00 AM ET).
March 30, 2026Initial compliance period deadline to regain Nasdaq's Minimum Bid Price Requirement.
August 6, 2026Deadline for stockholder proposals for the 2026 Annual Meeting.
2026 Annual MeetingTerm expiration for Class II directors (Douglas Maine, Helder Antunes, Alan Black).
January 1, 2026Commencement of annual increase in 2024 Equity Incentive Plan shares.
2027 Annual MeetingTerm expiration for Class III directors (Allen Salmasi, Kanishka Roy).
December 30, 2028Expiration date for Allen Salmasi's stock option award.
2028 Annual MeetingTerm expiration for Class I directors (Michael Salmasi, Gary Cohen).
January 1, 2034End date for annual increase in 2024 Equity Incentive Plan shares.

Keywords

VEEA, reverse stock split, Nasdaq compliance, equity incentive plan, corporate governance, executive compensation, proxy statement, stock dilution, related party transactions

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.